Precursors of plasma cells were studied in the bone marrow of 28 patients with multiple myeloma, plasma cell leukemia, and benign monoclonal gammopathy. Pre-B and B cell populations were analyzed with anti
Introduction
Plasma cells are at the final stage ofantigen-driven B lymphocyte activation, division, and differentiation, and they lose the capacity to proliferate (1) . Malignant plasma cells in multiple myeloma (MM)' have a low growth fraction with long cell cycle, the circulation, and only at the terminal phase of the disease. The disease may therefore spread through the circulating blood by precursor cells, which show lymphoid rather than plasma cell morphology. Transplantation experiments in murine myeloma have shown that neoplastic cells progressively differentiate from small, nonsecretory elements into large secretory plasmacytoid cells (4), and that the clonogenic cells that propagate the disease are present in the blood but lack myeloma cell morphology (5) .
In man, malignant plasma cell precursors have been studied with a clonogenic assay (6) , but the membrane marker features ofclonally expanding cells have not been established. The single specific marker for the MM malignant clones is their unique Ig idiotype. However, it is still unresolved whether or not pecursor cells in MM show idiotypic Ig determinants on their membrane and/or within their cytoplasm. In this paper, we have therefore investigated pre-B and B cell types in bone marrow (BM) samples infiltrated with MM. A range ofB cell and plasma cell associated monoclonal antibodies (MABs) corresponding to those standardized at the Leucocyte Typing Workshops in Paris (7) and Boston (8) were applied. In addition, we have attempted to induce plasma cell differentiation in the various populations with phorbol ester 12-0-tetradecanoyl-phorbol-13 acetate (TPA).
In the present paper, we provide evidence that in advanced forms of plasma cell malignancies such as MM, stages II and III (9) , and in plasma cell leukemia (PCL), cells of lymphoid morphology are present that express common acute lymphoblastic leukemia antigen (CALLA, CD10) and HLA-DR, but do not contain terminal deoxynucleotidyl transferase (TdT-) and are negative for both surface Ig (slg) and cytoplasmic Ig (cylg) as well as for B cell antigens CD [19] [20] [21] [22] . When these CALLA',Igcells are separated with a fluorescence-activated cell sorter (FACS) , and stimulated with TPA in vitro, the induced cells transform into plasma cells that synthesize the heavy and light chains displayed by the patients' myeloma cells.
Patients. (9) . Two patients (one male, 65-yr-old, and one female, 59-yr-old) had aggressive PCL, and presented with hepatosplenomegaly and anemia. Both had a rapid, fatal course. One patient, a 35-yr-old female, had isolated plas-macytoma (IP) with a single osteolytic lesion localized to the sternum. At this site the plasma cell infiltrate had IgG/k+ plasma cells, and at other sites the BM contained normal, low proportions (0.5-2%) of polyclonal plasma cells. A monoclonal serum component (1 g/dl) was detected in the serum. Three patients (one male, two females, aged 45, 50, and 52 yr) had benign monoclonal gammopathy (BMG). The levels of monoclonal Ig were <3 g/dl with <10% plasma cells in BM. Bone lesions, anemia, renal insufficiency, and other evidence ofdisease progression have not been observed in the 5-yr-period preceding our study.
Methods
Cells and tissues studied. The samples examined were: (a) BM tissue from 23 patients with MM and from three patients with BMG; (b) peripheral blood lymphocytes (PBL) from 14 patients with MM, two patients with PCL, and two patients with BMG; (c) a specimen of the neoplastic tissue obtained with biopsy from the patient with a plasmocytoma of the sternum. Plasma cells from normal healthy individuals were also studied. These were from: (a) the BM samples of four patients with no identifiable haematological disorders, as indicated by the normal histology seen on trephine biopsies; (b) five samples of tonsil tissue removed from children undergoing tonsillectomy after antibiotic treatment; (c) cells harvested from pokeweed mitogen (PWM)-stimulated peripheral blood. These cells were cultured for 8 d in flat-bottomed microtiter plates (Nunc, Kamstrup, Denmark). The stimulating dose of PWM (Gibco Laboratories, Grand Island, NY) was 4 ng/ml (I 1).
B blast cells deriving from the germinal center (GC) were separated from tonsils (three samples) with a FACS 420 (Becton-Dickinson & Co., Mountain View, CA). The tonsil suspensions were reacted with the MAB RFA-2, which detects an antigen expressed on both T cells in the paracortical region and B cells in the mantle zone, but not on GC B blasts (12). The cells unreactive with RFA-2 were sorted. Two acute lymphoblastic leukemia cell lines were also used in the present study: KM3 and Nalm-6 (13 Staining ofcells. MABs were either used as culture supernatants in 1:5 final dilution or as purified Ig (2.5-10 ug/ml, final dilution). Heterologous antisera were used at 1:50 final dilution. Cytospins were air dried, and fixed with cold acetone (for Ig and MAB-defined antigens) or with cold methanol (for TdT). MAB reactivity was defined by staining cells with two-color IF using the MAB plus G-anti-M-IgG-FITC or R-anti-M-IgM-FITC together with R-or G-anti-human Ig isotype-TRITC. The morphology of reacting cells was studied with the APAAP technique (22) . The TdT staining was performed as previously described (24).
Cell cultures. CALLA' cells were purified from five patients with MM (three samples of BM and two samples of PBL). J-5 and RFAL1 MABs, detecting identical epitopes on the p100 CALLA (CD110), were used for labeling and sorting on FACS 420. The CALLA' cells were suspended in RPMI 1640 medium plus 10% FCS at 1 X 106 cells/ml and incubated for 72 h in 25-cm2 tissue culture flasks (Nunc) at 37°C in air containing 5% CO2. Duplicate cultures were set up as controls, and parallel samples were stimulated with TPA (first dissolved in acetone, 1.6 X l0-3 M, and then in absolute alcohol, 1.6 X 10-M). The final TPA concentration in the cultures was 1.6 X 10-g M, which, in preliminary experiments (25), was found to be optimal for inducing phenotypic changes in B cell malignancies without decrease in viability. Control and TPA-induced cells were harvested after 72 h and assessed for viability by trypan blue. The cell morphology and membrane markers were analyzed on cytocentrifuge smears (see above). Additional controls included a range ofCALLA' cells, with both normal (GC B blasts) and malignant (Nalm 6 and KM3 cell lines) cultured under the same conditions.
Results
Cluster differentiation (CD) (Table II) . The cells of the solitary lesion in IP expressed the RFB6 (CD21) antigen (>85%; Table II ). The circulating plasma cells in PCL were also negative with B4, B1, RFB4, and RFB6 (Table II) . The small mononuclear cell subset (0.5-2% of BM cells) in these BM samples that reacted with these antibodies were >90% sIgM' and expressed K or X chains in a "polyclonal" fashion (residual normal B cells). BA2 (CD9) and BA 1 (CD24) were also unreactive with malignant plasma cells (<1%). In contrast, CALLA (CD10) was weakly expressed by a variable percentage of plasma cells in 10/23 MM patients (Fig. 1, a- Table III): 85±3% of these CALLA' cells had a lymphoid appearance, and only a minority (<15%) were plasmablasts or plasma cells (Fig.  2 ). Most lymphoid cells had an unremarkable morphology (Fig.   2 a) , but 5-10% had an irregular nuclear morphology, with indentations ( Fig. 2 b, arrow) or signs of immaturity such as one or two nucleoli. CALLA' cells with clear signs of plasmacytic differentiation (14±2%) were small in size and had a scanty cytoplasm (Fig. 2 c) . The proportions of morphologically identifiable plasma cells were similar to the percentages of IgC cells defined by immunofluorescence within the CALLA' population. The sorted CALLA' cells were also investigated with Bl-Biotin (CD20) and TlO-Biotin, and were found to be BI negative (<1%) and weakdy TIO positive (>90%).
CALLA' cells from MM can be induced to acquire plasma cell features. CALLA' cells from five patients were separated and cultured in vitro with or without TPA. After 72 h in vitro, the viability was >85%, with >80% cell recovery. The mitotic index was low (0-1%) in both groups. Cells in control cultures without TPA did not show significant morphological changes, but most cells (93±1.6%) had become CALLA-. The percentage of cyIg cells remained low (13±6%).
In contrast, the morphological analysis revealed changes in TPA-induced CALLA' cells (Fig. 3) . Most elements had enlarged, and the cytoplasm became strongly basophilic ( Fig. 3 a) ; 20-45% of cells had acquired the appearance of plasma cells (Fig. 3 b) , sometimes with cytoplasmic vacuoli. These TPAtransformed cells had lost CALLA (<1%), and no B-lineageassociated antigens could be detected on their membrane with antibodies CD 19-22. On the other hand, a high percentage (55±18%) of cells synthesized light and heavy chains (Fig. 3, c  and d) . In each individual case, the Ig produced were of the same isotype as expressed by fresh, unstimulated MM and PCL (Table IV) acquiring -y or a isotypes, membrane associated or cytoplasmic. Similarly, the morphology of Nalm-6 and KM3 CALLA' cells was unaltered by TPA induction and only some vacuoli appeared. CALLA expression was retained by these blast cells.
Nalm-6 cells remained cy-,g' (as was observed at the initiation of cultures), while KM3 remained Ig-. 
